Navigation Links
VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance
Date:8/18/2008

y disclosed in the Company's July 29, 2008 press release reduced earnings per share by three cents, from $0.56 to $0.53.

The condensed consolidated statement of operations for the three and six months ended June 30, 2008, along with other related disclosures in the accompanying notes, is contained in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 18, 2008.

Business Outlook

The Company is changing its earning guidance solely due to changes in stock-based compensation expense. VNUS currently expects full year stock based pre-tax compensation expense to increase by $762,000 or approximately four-and-a-half cents per share and range from $4.2 million to $4.6 million. Stock-based pre-tax compensation expense through the six months ended June 30, 2008 was $2.2 million.

Third quarter net income is expected to range from $0.9 million to $1.8 million or income of $0.06 to $0.11 per share. Adjusted EBITDA guidance for the third quarter remains unchanged at $2.0 million to $3.0 million. VNUS currently expects its full-year 2008 net income to range from approximately $12.4 million to $13.4 million, or income of $0.73 to $0.80 per share. VNUS expects Adjusted EBITDA to remain unchanged for the full year and range from $17.0 million to $18.1 million.

Non-GAAP Financial Information:

VNUS' management evaluates and makes operating decisions using various operating measures, including revenue growth and adjusted earnings before interest, taxes, depreciation and amortization, and non-cash charges for stock-based compensation (Adjusted EBITDA). The Company believes that these non-GAAP measures, when presented in conjunction with the comparable GAAP measures, are useful to both management and investors in analyzing the Company's ongoing business and operating performance. The Company believes that providing the non-GAAP information to investors, in addition to the GAAP presentation, allows
'/>"/>

SOURCE VNUS Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Arno Therapeutics Announces Second Quarter 2008 Financial Results
2. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
3. Yongye Biotechnology International Announces Second Quarter Results
4. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
5. China Kangtai Cactus Biotech Announces Record Second Quarter Results
6. AMDL Inc. Announces Second Quarter 2008 Results; Company Posts $5.8 Million in Sales With a Revenue Increase of 140%
7. SPO Medical Reports Second Quarter 2008 Results
8. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
9. China Biologic Products Reports Second Quarter 2008 Results
10. Neuralstem Reports Second Quarter Financial Results and Highlights
11. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., STOCKHOLM, November 20 Karol...pean Investment Fund (EIF) has entered into a,co-i...tment fund will be,managed by Karolinska Developme...f early-stage pharmaceutical and medical technolog... in the co-investment fund. The agreement,represen...
(Date:11/19/2009)...le would like to be able to charge their cell phon...too often. A recent discovery made by UC San Diego...ercapacitors that could do just this. , In rece... , Prabhakar Bandaru, a professor in the UCSD Depa...ong with graduate student Mark Hoefer, have found ...
(Date:11/19/2009)... ,, BETHESDA, Md., Nov. 19 /PRNewswire-First... innovator in biotechnology for diabetes therapy, ...ing services to food, supplement, biotechnology an...sed the previously reported $6.3 million registere...,760,870 shares of its common stock and warrants t...
(Date:11/19/2009)... MUNSTER, Germany, November 19 ...led on November 16th, 2009 Flibanserin in the,indi...sia in Parkinson,s,disease for orphan drug status ...EA). Levodopa-induced dyskinesia is a complication... and a serious burden to some of those,affected, s...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
...alifax-based consumer health products company reco...Nova Scotia, Jan. 27 Origin BioMed Inc., a privat..., today announced that it has been awarded as one ... , Red Herring Top 100 Global Companies are chosen...itions for North America, Europe and Asia Red Herr...
...EW YORK, Jan. 27 Technology and consulting firm, ...acle Partner Network, today announced year over ye...continue the positive trend in 2009. The company,...f flat to low single digit growth for the U.S. IT...rn affects IT services spending across most indust...
... ST. LOUIS and DURHAM, N.C., Jan. 27 As farmers.... Louis-based Monsanto,(NYSE: MON ) is exploring...e,traits through the seed. Monsanto,s new collabor...ed to do just that by expanding the benefits of,Mo...rmer customer. , Today, Monsanto announced tha...
Other Biology Technology:Origin BioMed Awarded Red Herring Top 100 Global Company 2Origin BioMed Awarded Red Herring Top 100 Global Company 3Fadel Partners Announces 13% Growth Despite IT Services Industry Downtrend 2New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 2New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 3New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 4
(Date:11/20/2009)...North Grafton, Mass., November 19, 2009 The estim...industry may be at risk of developing respiratory ...ccording to a questionnaire study undertaken earli...s Cummings School of Veterinary Medicine. , The ...arn workersfound that 50 percent of individuals wo...
(Date:11/20/2009)... This release is available in German . , In...cal Investigation , Dr. Stefanie Eyerich and Dr. K...Imperial College London and Istituto Dermopatico d...ng discovery. It represents a milestone on the way...ory skin diseases such as psoriasis and allergic r...
(Date:11/20/2009)...CHAMPAIGN, Ill. In a new study, researchers repor...ockers can have a helpful, or harmful, effect on t..., The study, which appears in the journal Circul...get both the alpha- and beta-receptors on the hear...s, while those that target only the beta-receptors...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Carvedilol shown to have unique characteristics among beta blockers 2University of Toronto helps to barcode the worlds plants 9394 1University of Toronto helps to barcode the worlds plants 9394 2Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 1Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 2Valve Repair First in New England Done With Robotic Device 52959 1Valve Repair First in New England Done With Robotic Device 52959 2Valve Repair First in New England Done With Robotic Device 52959 3
...mproved aerodynamic shape for truck trailers by mo...ption and emissions of up to as much as 15%. Earli...dels and wind tunnel tests by TU Delft, have been ...r. This means that public-private platform PART (P...ced an application which can immediately be put in...
...e most common cause of episodic headache, and by f... visit. It affects some 15% of the population, inc...s a considerable burden on healthcare in both the ... last few years, great strides have been made in d...lity to common diseases, such as diabetes, Crohns ...
...y: New evidence has emerged that, contrary to some... associated with an increased risk of heart proble...cancer recurring. , In a study presented today (T...nce (EBCC-6) in Berlin, the researcher, Dr Alain M...g news for women. , AIs, such as letrozole, anast...
Other Biology News:Aerodynamic trailer cuts fuel and emissions by up to 15 percent 2Concentrating on different aspects of pain leads to breakthrough in migraine genetics 2New research shows no link between aromatase inhibitors and cardiovascular problems 2New research shows no link between aromatase inhibitors and cardiovascular problems 3
Goat Anti-SDF-1 beta / PBSF Polyclonal Antibody, Unconjugated from Sigma-Aldrich
Immulon 4 HBX 1x12 Strip from Thermo Scientific
BspT107 I (HgiC I, Ban I) from Takara Mirus Bio
Enterokinase from bovine intestine from Sigma-Aldrich
Biology Products: